Kubota Vision Inc.
https://www.kubotavision.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kubota Vision Inc.
Multiple Stargardt Contenders Progress In Japan Despite Small Market
With no approved therapies globally for Stargardt's, competition in the indication is increasing in Japan, where Kubota Vision is seeking for conditional approval for emixustat, while Belite Bio’s contender tinlarebant has received Sakigake designation as a local Phase III program continues.
Company Information
- Industry
- Pharmaceuticals
-
Medical Devices
- Monitoring Equipment & Devices
-
Biotechnology
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
-
- Acucela Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice